UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

___________

FORM 8-K

___________

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

DATE OF REPORT (Date of Earliest Event Reported):   November 2, 2010

EXPEDITE 5, INC.

(Exact Name of Registrant As Specified In Charter)

DELAWARE	000-52869
(State or Other Jurisdiction of Incorporation or Organization)	(Commission File No.)	(IRS Employee Identification No.)

21 Arlington Street

London, United Kingdom SW1A 1RN

(Address of Principal Executive Offices)

44 20 7491 6414

(Issuer Telephone Number)

212 Carnegie Center #206

Princeton, NJ 08540

 (Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 1.01 Entry into a Material Definitive Agreement

On November 2, 2010, Expedite 5, Inc. (the “Company”) consummated a subscription agreement originally dated May 6, 2010 with an accredited investor (the “Subscription Agreement”) pursuant to which the Company agreed to issue and sell to the investors and the investors agreed to purchase from the Company an aggregate of 500,000 shares of Common Stock, par value $0.001 per share (the “Common Stock”) of the Company. Additional information required to be disclosed in this Item 1.01 concerning these transactions is incorporated herein by reference from Item 3.02 of this Current Report on Form 8-K.

ITEM 3.02 UNREGISTERED SALES OF EQUITY SECURITIES

On November 2, 2010, the Company consummated the Subscription Agreement as part of a confidential private placement (the “Private Offering”) for the issuance and sale of 500,000 shares of the Company’s Common Stock at a per share price of $1.00 for aggregate offering proceeds of $500,000.

The Private Offering was conducted on a best efforts basis by the Company’s officers and directors, with a minimum investment of $250,000. The gross proceeds received by the Company including this final consummated subscription was $4,000,000, including proceeds of $3,500,000 notified in the 8-K filing dated May 10, 2010.

The Private Offering and issuance of shares to the investors was an unregistered sale of securities conducted pursuant to Rule 506 of Regulation D or Regulation S promulgated thereunder. Such securities were not registered under the Securities Act of 1933. 

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.

(a)	Financial statements of business acquired:
	None
(b)	Pro Forma Financial Information
	None
(c)	Shell company transactions. None
(d)	Exhibits.
	Exhibit #	Description
	None

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

EXPEDITE 5, INC
By:	/s/Mark Opzoomer
	Mark Opzoomer President, Chief Executive Officer and Director
By:	/s/ Rob Gorle
	Rob Gorle
	CFO, Director and Secretary

 Dated: November 8, 2010

3